The clinical characteristics and treatment for sudden sensorineural hearing loss with vestibular schwannoma.
The aim of this study is to analyze the clinical characteristics and treatment of sudden sensorineural hearing loss (SSNHL) patients with vestibular schwannoma (VS). The clinical features of the VS patients were explored by retrospectively analyzing the clinical data from 542 cases of SSNHL patients between January 2008 and March 2013. There were 10 cases (10 ears) diagnosed with VS in 542 cases of SSNHL patients (10 ears, 1.85 %), 3 males, 7 females, with a range of 28-57 years. Among all the cases, eight patients with abnormal ABR, ten with ear ipsilateral stapedius reflexes which were completely not elicited and seven patients with healthy ear contralateral stapedius reflexes which were completely not elicited. Neuromas were classified by Koos grades according to size (8 of grade I, 1 of grade II, 1 of grade IV). Eight small VS  patients were taken waiting and MRI therapy strategies. Meanwhile, we used glucocorticoid treatment and timely and short-term medication to improve the microcirculation of the inner ear for these patients. And four cases' hearing was improved. Some vestibular schwannomas have SSNHL as initial symptoms, especially the small ones in internal auditory canal. To prevent misdiagnosis or leak-diagnosis, MRI should be performed as a routine test for SSNHL, and ABR is sometimes necessary for SSNHL patients. It is also necessary to give appropriate treatment to protect hearing of the small vestibular schwannoma patients whose first symptoms are diagnosed as SSNHL in acute phase.
Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China. linc301@yahoo.com.
Chang
C
Lin
Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Qilin
Q
Gong
Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Wenjing
W
Zuo
Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Rong
R
Zhang
Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Aidong
A
Zhou
D000328:Adult; D002681:China; D003951:Diagnostic Errors / Q000517:prevention & control*; D007758:Ear, Inner / Q000098:blood supply / Q000473:pathology; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D003639:Hearing Loss, Sudden / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000150:complications*; D012189:Retrospective Studies
D005938:Glucocorticoids